Fresenius Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Fresenius Medical Care
FMS Stock  USD 23.51  0.31  1.30%   
Fresenius Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Fresenius Medical's valuation are provided below:
Gross Profit
4.9 B
Profit Margin
0.0366
Market Capitalization
13.6 B
Enterprise Value Revenue
1.0393
Revenue
19.6 B
There are over one hundred nineteen available fundamental signals for Fresenius Medical Care, which can be analyzed over time and compared to other ratios. All traders should verify Fresenius Medical's prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 11.5 B in 2026. Enterprise Value is likely to drop to about 16.5 B in 2026

Fresenius Medical Total Revenue

11.73 Billion

Check Fresenius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fresenius Medical's main balance sheet or income statement drivers, such as Interest Expense of 268.2 M, Total Revenue of 11.7 B or Gross Profit of 3.7 B, as well as many indicators such as Price To Sales Ratio of 1.47, Dividend Yield of 0.0123 or PTB Ratio of 0.96. Fresenius financial statements analysis is a perfect complement when working with Fresenius Medical Valuation or Volatility modules.
  
Build AI portfolio with Fresenius Stock
Check out the analysis of Fresenius Medical Correlation against competitors.

Fresenius Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding664.6 M674.9 M667.7 M
Slightly volatile
Total Assets19.3 B38.6 B25.5 B
Slightly volatile
Short and Long Term Debt Total6.5 B12.7 B9 B
Slightly volatile
Other Current Liabilities1.9 B3.6 B2.3 B
Slightly volatile
Total Current Liabilities3.8 B6.5 B4.8 B
Slightly volatile
Total Stockholder Equity17.6 B16.8 B10.8 B
Slightly volatile
Property Plant And Equipment Net8.8 B8.3 B5 B
Slightly volatile
Net Debt5.9 B11.3 B8.1 B
Slightly volatile
Retained Earnings13.6 B13 B8.2 B
Slightly volatile
Accounts Payable1.2 B1.1 B765.5 M
Slightly volatile
Cash1.4 B1.4 B968.7 M
Slightly volatile
Non Current Assets Total31 B29.5 B20.1 B
Slightly volatile
Cash And Short Term Investments1.6 B1.5 B1.1 B
Slightly volatile
Net Receivables2.5 B3.9 B3.1 B
Slightly volatile
Common Stock Total Equity304.7 M336.8 M299.8 M
Slightly volatile
Liabilities And Stockholders Equity19.3 B38.6 B25.5 B
Slightly volatile
Non Current Liabilities Total7.4 B14 B9.7 B
Slightly volatile
Inventory2.5 B2.4 B1.5 B
Slightly volatile
Other Current Assets711.4 M1.3 B779.4 M
Slightly volatile
Other Stockholder Equity3.2 B3.8 B3.3 B
Slightly volatile
Total Liabilities11.1 B20.5 B14.5 B
Slightly volatile
Property Plant And Equipment Gross16.1 B16.9 B7 B
Slightly volatile
Total Current Assets5 B9.1 B6.4 B
Slightly volatile
Short Term Debt1.1 B1.4 B1.4 B
Slightly volatile
Intangible Assets1.3 B1.2 B1.1 B
Pretty Stable
Common Stock261 M337.4 M280.7 M
Slightly volatile
Other Liabilities3.2 B3.1 B2 B
Slightly volatile
Other Assets502.4 M492 M637.5 M
Slightly volatile
Long Term Debt5.8 B7.2 B6.5 B
Pretty Stable
Property Plant Equipment8.8 B8.3 B5.4 B
Slightly volatile
Good Will13 B13.7 B11.8 B
Slightly volatile
Short Term Investments155.5 M187.6 M130.1 M
Slightly volatile
Long Term Investments911.9 M1.6 B851.9 M
Slightly volatile
Short and Long Term Debt493.7 M519.6 M2.9 B
Slightly volatile
Long Term Debt Total9.7 B11.2 B8.5 B
Slightly volatile
Capital Surpluse2.8 B3 B3.7 B
Slightly volatile
Net Invested Capital20.7 B24.6 B18.6 B
Slightly volatile
Cash And Equivalents383.2 M308.6 M413.5 M
Very volatile
Net Working Capital1.5 B2.6 B1.3 B
Slightly volatile
Capital Stock237.5 M264.1 M296.7 M
Slightly volatile

Fresenius Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue11.7 B22.2 B15.2 B
Slightly volatile
Gross Profit3.7 B5.5 B4.6 B
Slightly volatile
Operating Income1.6 B1.6 B2 B
Slightly volatile
EBIT1.6 B1.7 B2 B
Slightly volatile
EBITDA2.3 B3.7 B3 B
Slightly volatile
Net Income708.2 M618.6 M895.6 M
Very volatile
Depreciation And Amortization2.1 B2 B1.1 B
Slightly volatile
Selling General Administrative2 B2.1 B2.4 B
Slightly volatile
Other Operating Expenses10.5 B20.6 B13.5 B
Slightly volatile
Research Development110.6 M211 M146.1 M
Slightly volatile
Cost Of Revenue17.6 B16.8 B11.3 B
Slightly volatile
Total Operating Expenses2.2 B3.9 B2.8 B
Slightly volatile
Income Before Tax1.2 B1.2 B1.5 B
Very volatile
Net Income Applicable To Common Shares902.8 M618.6 M973.5 M
Pretty Stable
Net Income From Continuing Ops1.1 B666.8 M1.3 B
Slightly volatile
Tax Provision347.3 M284.5 M458.8 M
Slightly volatile
Interest Income61.2 M64.4 M269.2 M
Slightly volatile
Reconciled Depreciation1.6 B2 B1.2 B
Slightly volatile
Selling And Marketing Expenses636.1 M698.9 M784.2 M
Slightly volatile

Fresenius Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow1.7 B1.6 B965.5 M
Slightly volatile
Depreciation2.1 B2 B1.1 B
Slightly volatile
Capital Expenditures1 B804.3 M1.3 B
Very volatile
Total Cash From Operating Activities1.6 B2.7 B2 B
Slightly volatile
Net Income856.3 M852 M1.1 B
Very volatile
End Period Cash Flow1.4 B1.4 B970.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.470.761.3328
Slightly volatile
Dividend Yield0.01230.02440.0156
Slightly volatile
PTB Ratio0.961.011.9877
Slightly volatile
Days Sales Outstanding84.8574.076.2093
Slightly volatile
Book Value Per Share25.3524.1416.4194
Slightly volatile
Operating Cash Flow Per Share3.843.652.9809
Slightly volatile
Average Payables734.2 M699.2 M671.8 M
Slightly volatile
Stock Based Compensation To Revenue0.00150.00190.0014
Pretty Stable
Capex To Depreciation0.440.461.4713
Slightly volatile
PB Ratio0.961.011.9877
Slightly volatile
EV To Sales1.391.061.772
Slightly volatile
ROIC0.07610.03850.0621
Pretty Stable
Inventory Turnover9.38.117.8822
Slightly volatile
Net Income Per Share0.790.821.2926
Pretty Stable
Days Of Inventory On Hand35.4546.5947.1683
Pretty Stable
Payables Turnover11.7713.3314.2609
Pretty Stable
Sales General And Administrative To Revenue0.0960.110.1199
Slightly volatile
Average Inventory1.2 B1.2 B1.1 B
Slightly volatile
Research And Ddevelopement To Revenue0.0070.00850.0092
Slightly volatile
Capex To Revenue0.05520.03260.0784
Slightly volatile
Cash Per Share2.162.061.5414
Slightly volatile
POCF Ratio5.886.1910.2063
Slightly volatile
Interest Coverage5.43.934.8422
Pretty Stable
Payout Ratio0.450.750.5063
Pretty Stable
Capex To Operating Cash Flow0.660.340.6714
Slightly volatile
Days Payables Outstanding28.628.3425.7152
Pretty Stable
Income Quality2.573.72.7872
Pretty Stable
ROE0.03160.03320.088
Slightly volatile
EV To Operating Cash Flow16.3610.9314.4642
Slightly volatile
PE Ratio33.5727.4824.9174
Very volatile
Return On Tangible Assets0.0270.02840.0721
Slightly volatile
Earnings Yield0.03580.03770.0459
Pretty Stable
Intangibles To Total Assets0.580.570.5205
Slightly volatile
Current Ratio1.531.611.433
Slightly volatile
Receivables Turnover3.825.14.8214
Slightly volatile
Graham Number25.4340.6739.2524
Pretty Stable
Shareholders Equity Per Share23.4322.3215.2036
Slightly volatile
Debt To Equity0.590.680.8571
Very volatile
Capex Per Share0.991.071.6769
Slightly volatile
Average Receivables1.4 B2.8 B2.7 B
Slightly volatile
Revenue Per Share31.0829.622.705
Slightly volatile
Interest Debt Per Share18.3417.4713.0007
Slightly volatile
Debt To Assets0.230.30.3381
Very volatile
Enterprise Value Over EBITDA7.216.379.1792
Slightly volatile
Short Term Coverage Ratios3.913.722.4845
Pretty Stable
Price Earnings Ratio33.5727.4824.9174
Very volatile
Operating Cycle97.16105121
Slightly volatile
Price Book Value Ratio0.961.011.9877
Slightly volatile
Days Of Payables Outstanding28.628.3425.7152
Pretty Stable
Dividend Payout Ratio0.450.750.5063
Pretty Stable
Price To Operating Cash Flows Ratio5.886.1910.2063
Slightly volatile
Pretax Profit Margin0.07890.04920.0992
Slightly volatile
Ebt Per Ebit0.580.680.7758
Very volatile
Operating Profit Margin0.150.08280.1282
Slightly volatile
Effective Tax Rate0.370.340.3219
Slightly volatile
Company Equity Multiplier1.982.072.4738
Slightly volatile
Long Term Debt To Capitalization0.270.30050.3674
Slightly volatile
Total Debt To Capitalization0.330.390.4536
Pretty Stable
Return On Capital Employed0.05450.05740.0938
Slightly volatile
Debt Equity Ratio0.590.680.8571
Very volatile
Ebit Per Revenue0.150.08280.1282
Slightly volatile
Quick Ratio1.231.191.1287
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.262.051.5731
Slightly volatile
Net Income Per E B T0.460.50890.5466
Very volatile
Cash Ratio0.10.190.1752
Slightly volatile
Cash Conversion Cycle76.3682.3396.1765
Slightly volatile
Operating Cash Flow Sales Ratio0.0960.110.1282
Pretty Stable
Days Of Inventory Outstanding35.4546.5947.1683
Pretty Stable
Days Of Sales Outstanding84.8574.076.2093
Slightly volatile
Cash Flow Coverage Ratios0.330.250.2363
Pretty Stable
Price To Book Ratio0.961.011.9877
Slightly volatile
Fixed Asset Turnover4.93.063.8512
Slightly volatile
Capital Expenditure Coverage Ratio1.713.072.1538
Slightly volatile
Price Cash Flow Ratio5.886.1910.2063
Slightly volatile
Enterprise Value Multiple7.216.379.1792
Slightly volatile
Debt Ratio0.230.30.3381
Very volatile
Cash Flow To Debt Ratio0.330.250.2363
Pretty Stable
Price Sales Ratio1.470.761.3328
Slightly volatile
Return On Assets0.01370.01440.035
Slightly volatile
Asset Turnover0.730.660.6196
Pretty Stable
Net Profit Margin0.04470.0250.0593
Slightly volatile
Gross Profit Margin0.360.280.3146
Slightly volatile
Price Fair Value0.961.011.9877
Slightly volatile
Return On Equity0.03160.03320.088
Slightly volatile

Fresenius Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap11.5 B11.6 B19.6 B
Very volatile
Enterprise Value16.5 B20.4 B27.7 B
Pretty Stable

Fresenius Fundamental Market Drivers

Forward Price Earnings9.4787
Cash And Short Term Investments1.3 B

Fresenius Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Fresenius Medical Financial Statements

Fresenius Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Fresenius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Fresenius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Fresenius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue73.9 M70.3 M
Total Revenue22.2 B11.7 B
Cost Of Revenue16.8 B17.6 B
Sales General And Administrative To Revenue 0.11  0.10 
Research And Ddevelopement To Revenue 0.01  0.01 
Capex To Revenue 0.03  0.06 
Revenue Per Share 29.60  31.08 
Ebit Per Revenue 0.08  0.15 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Fresenius Stock Analysis

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY